Mangoceuticals (MGRX) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MGRX Stock Alerts $0.26 -0.01 (-3.66%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Mangoceuticals Short Interest DataCurrent Short Volume197,600 sharesPrevious Short Volume692,100 sharesChange Vs. Previous Month-71.45%Dollar Volume Sold Short$48,214.40Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares24,620,000 sharesFloat Size13,570,000 sharesShort Percent of Float1.46%Today's Trading Volume63,689 sharesAverage Trading Volume212,494 sharesToday's Volume Vs. Average30% Short Selling Mangoceuticals ? Sign up to receive the latest short interest report for Mangoceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMGRX Short Interest Over TimeMGRX Days to Cover Over TimeMGRX Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Mangoceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024197,600 shares $48,214.40 -71.5%1.5%0.2 $0.24 3/31/2024692,100 shares $150,117.18 +364.2%5.3%0.6 $0.22 3/15/2024149,100 shares $26,405.61 +16.0%1.2%0.1 $0.18 2/29/2024128,500 shares $28,861.10 -81.0%1.1%0.1 $0.22 2/15/2024674,500 shares $158,844.75 +75.4%5.5%0.8 $0.24 1/31/2024384,500 shares $138,804.50 +104.0%4.0%0.5 $0.36 Get the Latest News and Ratings for MGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024188,500 shares $57,492.50 +195.0%2.6%0.3 $0.31 12/31/202363,900 shares $17,693.91 -57.9%0.9%0.1 $0.28 12/15/2023151,800 shares $46,602.60 +204.8%2.1%0.4 $0.31 11/30/202349,800 shares $36,802.20 +333.0%0.7%0.2 $0.74 11/15/202311,500 shares $5,012.85 -90.4%0.2%0 $0.44 10/31/2023120,300 shares $75,789.00 +620.4%1.7%0.5 $0.63 10/15/202316,700 shares $10,688.00 +153.0%0.2%0.1 $0.64 9/30/20236,600 shares $5,613.30 -82.8%0.1%0.1 $0.85 9/15/202338,400 shares $38,016.00 +18.5%0.6%0.4 $0.99 8/31/202332,400 shares $40,176.00 -22.5%0.5%0 $1.24 8/15/202341,800 shares $45,562.00 +5.8%0.6%0 $1.09 7/31/202339,500 shares $45,030.00 -13.9%0.6%0 $1.14 7/15/202345,900 shares $77,112.00 -51.9%0.8%0 $1.68 6/30/202395,400 shares $174,582.00 -79.6%1.6%0 $1.83 6/15/2023468,400 shares $726,020.00 +187.5%7.8%0.2 $1.55 5/31/2023162,900 shares $182,448.00 +10.4%2.9%0 $1.12 5/15/2023147,500 shares $181,425.00 No Change2.6%0 $1.23 MGRX Short Interest - Frequently Asked Questions What is Mangoceuticals' current short interest? Short interest is the volume of Mangoceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 197,600 shares of MGRX short. 1.46% of Mangoceuticals' shares are currently sold short. Learn More on Mangoceuticals' current short interest. What is a good short interest percentage for Mangoceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.46% of Mangoceuticals' floating shares are currently sold short. Is Mangoceuticals' short interest increasing or decreasing? Mangoceuticals saw a drop in short interest in April. As of April 15th, there was short interest totaling 197,600 shares, a drop of 71.4% from the previous total of 692,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mangoceuticals' float size? Mangoceuticals currently has issued a total of 24,620,000 shares. Some of Mangoceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mangoceuticals currently has a public float of 13,570,000 shares. How does Mangoceuticals' short interest compare to its competitors? 1.46% of Mangoceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mangoceuticals: BioRestorative Therapies, Inc. (0.82%), Ontrak, Inc. (6.67%), Sonendo, Inc. (0.68%), Psyence Biomedical Ltd. (5.16%), Titan Pharmaceuticals, Inc. (1.72%), Creative Medical Technology Holdings, Inc. (1.76%), Enveric Biosciences, Inc. (1.40%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), Cadrenal Therapeutics, Inc. (2.04%), Heart Test Laboratories, Inc. (1.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mangoceuticals stock? Short selling MGRX is an investing strategy that aims to generate trading profit from Mangoceuticals as its price is falling. MGRX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mangoceuticals? A short squeeze for Mangoceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGRX, which in turn drives the price of the stock up even further. How often is Mangoceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGRX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BRTX Short Squeeze OTRK Short Squeeze SONX Short Squeeze PBM Short Squeeze TTNP Short Squeeze CELZ Short Squeeze ENVB Short Squeeze SHPH Short Squeeze CVKD Short Squeeze HSCS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGRX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press